101 related articles for article (PubMed ID: 22123497)
21. AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells.
Carpi S; Fogli S; Romanini A; Pellegrino M; Adinolfi B; Podestà A; Costa B; Da Pozzo E; Martini C; Breschi MC; Nieri P
Anticancer Drugs; 2015 Aug; 26(7):754-62. PubMed ID: 25974027
[TBL] [Abstract][Full Text] [Related]
22. Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.
Griebel G; Stemmelin J; Scatton B
Biol Psychiatry; 2005 Feb; 57(3):261-7. PubMed ID: 15691527
[TBL] [Abstract][Full Text] [Related]
23. Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects.
Bifulco M; Grimaldi C; Gazzerro P; Pisanti S; Santoro A
Mol Pharmacol; 2007 Jun; 71(6):1445-56. PubMed ID: 17327463
[TBL] [Abstract][Full Text] [Related]
24. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice.
Liu YL; Connoley IP; Wilson CA; Stock MJ
Int J Obes (Lond); 2005 Feb; 29(2):183-7. PubMed ID: 15558076
[TBL] [Abstract][Full Text] [Related]
25. The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain.
Erdozain AM; Diez-Alarcia R; Meana JJ; Callado LF
Biochem Pharmacol; 2012 Jan; 83(2):260-8. PubMed ID: 22093909
[TBL] [Abstract][Full Text] [Related]
26. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
27. Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants.
Jourdan T; Demizieux L; Gresti J; Djaouti L; Gaba L; Vergès B; Degrace P
Hepatology; 2012 Mar; 55(3):790-9. PubMed ID: 21987372
[TBL] [Abstract][Full Text] [Related]
28. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes.
Gary-Bobo M; Elachouri G; Scatton B; Le Fur G; Oury-Donat F; Bensaid M
Mol Pharmacol; 2006 Feb; 69(2):471-8. PubMed ID: 16282221
[TBL] [Abstract][Full Text] [Related]
29. CB(1) receptor antagonism: biological basis for metabolic effects.
Di Marzo V
Drug Discov Today; 2008 Dec; 13(23-24):1026-41. PubMed ID: 18824122
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
[TBL] [Abstract][Full Text] [Related]
32. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
Roser P; Vollenweider FX; Kawohl W
World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
[TBL] [Abstract][Full Text] [Related]
33. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity.
Motaghedi R; McGraw TE
Obesity (Silver Spring); 2008 Aug; 16(8):1727-34. PubMed ID: 18551116
[TBL] [Abstract][Full Text] [Related]
34. SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats.
Lallemand F; De Witte P
Alcohol; 2006 Jul; 39(3):125-34. PubMed ID: 17127132
[TBL] [Abstract][Full Text] [Related]
35. Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice.
Comelli F; Bettoni I; Colombo A; Fumagalli P; Giagnoni G; Costa B
Eur J Pharmacol; 2010 Jul; 637(1-3):62-9. PubMed ID: 20399204
[TBL] [Abstract][Full Text] [Related]
36. Early tolerance to the hypophagic effect of the cannabinoid receptor antagonist SR141716 does not impede blockade of an orexigenic stimulus.
Rigamonti AE; Giordani C; Bonomo SM; Cella SG; Müller EE
Eur J Pharmacol; 2006 Aug; 542(1-3):116-20. PubMed ID: 16806163
[TBL] [Abstract][Full Text] [Related]
37. Bladder function in a cannabinoid receptor type 1 knockout mouse.
Füllhase C; Campeau L; Sibaev A; Storr M; Hennenberg M; Gratzke C; Stief C; Hedlund P; Andersson KE
BJU Int; 2014 Jan; 113(1):144-51. PubMed ID: 24053792
[TBL] [Abstract][Full Text] [Related]
38. Telomerase reverse transcriptase (TERT) expression and role of vincristine sulfate in mouse model of malignancy related peritoneal ascites: an experimental metastatic condition.
Chaklader M; Das P; Pereira JA; Chatterjee S; Basak P; Law A; Banerjee T; Chauhan S; Law S
Exp Oncol; 2011 Jun; 33(2):83-9. PubMed ID: 21716204
[TBL] [Abstract][Full Text] [Related]
39. Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.
Bell-Anderson KS; Aouad L; Williams H; Sanz FR; Phuyal J; Larter CZ; Farrell GC; Caterson ID
Int J Obes (Lond); 2011 Dec; 35(12):1539-48. PubMed ID: 21386801
[TBL] [Abstract][Full Text] [Related]
40. Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.
Kumar Srivastava B; Soni R; Patel JZ; Jha S; Shedage SA; Gandhi N; Sairam KV; Pawar V; Sadhwani N; Mitra P; Jain MR; Patel PR
Bioorg Med Chem Lett; 2008 Jul; 18(14):3882-6. PubMed ID: 18585913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
